CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 78 enrolled
Drug / intervention
Lens 1 (etafilcon A) +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02568254
NCT02568254N/ACompleted
CompareCT.gov

Evaluation of Three Daily Disposable Contact Lenses

Johnson & Johnson Vision Care, Inc.·interventional·Posted Oct 5, 2015·Updated Jul 17, 2017

In Brief

A clinical study evaluating Lens 1 (etafilcon A), Lens 2 (nelfilcon A), and 1 other intervention for Visual Acuity. Completed, enrolled 78 participants across 1 site.

Detailed Summary

This is a single-site, 8-visit, double-masked, cross-over study involving three marketed products as study lenses. Participants will be randomly assigned each lens type, which will be worn for approximately two weeks (12 +/- 2 days) each. Participants will undergo a minimum washout period of 3 days before entering the study and undergo a minimum 7 day washout period between dispensing each lens type.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesCanada
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedOct 5, 2015
Enrollment StartSep 3, 2015
Primary CompletionJan 18, 2016
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 10.7 years ago

Interventions

Lens 1 (etafilcon A)device

Each lens type will be worn for approximately 2 weeks (12 +/- 2 days).

Lens 2 (nelfilcon A)device

Each lens type will be worn for approximately 2 weeks (12 +/- 2 days).

Lens 3 (nesofilcon A)device

Each lens type will be worn for approximately 2 weeks (12 +/- 2 days).